Production of fibroblast master and working cell banks this task shall require establishment of all necessary technology transfer agreements between the requesting investigator and the contractor.…
Ended Awarded Last action
- Contract number
- HHSN26800003
- Awardee
-
University Of Miami UEI F8THLJQSAF93 Part of University Of Miami
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $723,091
Award facts
- Opportunity
-
- RECOVERY Acquisition of Computers and Computer Peripheral Equipment Special Notice · HHSN26817HB00014TO · Posted Jun 24, 2009
- Contract value 100% obligated
- $723,091.34 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- South Miami, FL 33146, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$1,582 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $724,673 |
About this award
The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $723,091.34 delivery order contract to the University of Miami to produce fibroblast master and working cell banks. The contract is part of the larger Production Assistance for Cellular Therapies - Cell Processing Facilities (PACT-CPF) indefinite delivery, indefinite quantity (IDIQ) contract vehicle. The work requires the University of Miami to establish necessary technology transfer agreements, develop timelines and milestones, acquire current procedures and standard operating procedures, and provide the requested manufacturing services. This is a cost-no-fee contract with an October 31, 2021 completion date. No set-aside designation was used.
Description
Production of fibroblast master and working cell banks this task shall require establishment of all necessary technology transfer agreements between the requesting investigator and the contractor. Upon completion of the agreements, the contractor shall 1) establish a timeline, milestones and decision points in collaboration with the requesting investigator; 2) acquire from the RSA investigator the current laboratory procedures and manufacturing standard operating procedures (SOPS) to culture and expand cells for a fibroblast cell bank; and 3) provide the manufacturing services requested in RSA PCT0009-1 (see attachment 1A).
Quick answers
Who was awarded contract HHSN26800003?
HHSN26800003 was awarded to University Of Miami by National Heart Lung and Blood Institute (National Institutes of Health) on December 1, 2017.
How much is contract HHSN26800003 worth?
The government has obligated $723,091 on HHSN26800003.
Is contract HHSN26800003 an order under another contract?
Yes. HHSN26800003 is a delivery order under HHSN268201600012I, an indefinite delivery contract, on Production Assistance for Cellular Therapies - Cell Processing Facilities (PACT-CPF).
Was contract HHSN26800003 competed?
The extent of competition for HHSN26800003 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award